|
|
|
| AI Meets Informed Consent: Opportunity, Risk, & What IRBs Need to See | As generative AI begins shaping how consent materials are created and delivered, sponsors and CROs face new ethical and regulatory challenges. This session explores core consent principles, emerging AI applications, and what IRBs need to know. Clinical operations leaders will gain a framework for evaluating AI assisted consent tools, improving IRB collaboration, and protecting participant understanding and autonomy. Click here to learn more. |
|
|
|
| What Sites, Sponsors, Vendors, And CROs Can All Agree On | Guest Column | By Abby Proch, executive editor, Clinical Leader | Experts representing sponsors, sites, vendors, and CROS discussed at Life Sciences Future SW the pain points and the opportunities that lie ahead in clinical research. |
|
|
| Empowering Mid-Size Pharma Companies With Integrated Services | White Paper | By Michelle Gyzen, Brian Healey, and Claire Davies, IQVIA Safety & Regulatory Compliance | A consultative, tech-enabled CRO can help mid-size pharma achieve targets by supplementing skillsets, expanding global reach, and designing an effective clinical, regulatory, and operational strategy. |
|
|
| Is Your Help Desk A Lifeline Or A Landline? | Article | Endpoint Clinical | A help desk should accelerate trial success, not create delays. Discover how proactive support and modern tools turn help desks into strategic assets that improve efficiency and reduce risk. |
|
|
| SMART First Human Dose (FHD) | Brochure | PCI Pharma Services | A CDMO with the right team of experts can aid drug development, regulatory compliance, and clinical trial supply, accelerating timelines to first human dose clinical trials and the path to market. |
|
|
| Commercial Drug Sourcing For Clinical Trials | Video | Catalent | Learn how the right partner can leverage years of experience, market knowledge, industry relationships, and clinical packaging expertise to develop a sourcing strategy tailored to the needs of each study. |
|
|
| Autoinjector, Pen, And Prefilled Syringe Capabilities | Brochure | Thermo Fisher Scientific | Flexible, scalable capabilities for autoinjectors, pens, and prefilled syringes — ranging from manual to fully automated — streamlining and simplifying your biologic drug development supply chain. |
|
|
|
| India Opens The Fast Lane For Drug Development | Guest Column | By Gunjan Bagla, Amritt Inc. | New in 2026, extensive reforms to India’s clinical trial rules are slashing approval timelines in half and eliminating licenses that once took months to obtain. |
|
|
|
| Automated Evidence Generation For Regulatory-Grade RWD | White Paper | Castor | Global regulatory agencies increasingly adopt Real-World Evidence, demanding higher data quality and automated AI-driven platforms to meet evolving standards and improve drug development pathways. |
|
|
|
CHOOSE YOUR OWN ADVENTURE |
|
|
|
| You're receiving the Thursday edition of the Clinical Leader newsletter, focusing on Outsourcing Models and Regulatory & Compliance. To make changes to your newsletter selections, update your topic preferences. - Clinical Sites | Patient Centricity | Patient Recruitment (Monday)
- Clinical Trial Technology (Tuesday)
- Decentralized Trials | Trial Management (Wednesday)
- Outsourcing Models | Regulatory & Compliance (Thursday)
- Clinical Data Management & Analytics | Trial Monitoring (Friday)
Learn more about our personalized newsletters here. |
|
|
| Connect With Clinical Leader: |
|
|
|
